![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9794|56|3|171-177
ISSN: 0009-3157
Source: Chemotherapy, Vol.56, Iss.3, 2010-04, pp. : 171-177
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer
Chemotherapy, Vol. 56, Iss. 2, 2010-03 ,pp. :